Five Prime Therapeutics, Inc. Operating Lease, Payments
Five Prime Therapeutics, Inc. reported Operating Lease, Payments of $7.86 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2021-03-22
- Five Prime Therapeutics, Inc. operating lease, payments for the quarter ending 2020-12-31 was $1.85M, a 3.46% increase year-over-year.
- Five Prime Therapeutics, Inc. operating lease, payments for the quarter ending 2020-09-30 was $2.20M, a 15.79% increase year-over-year.
- Five Prime Therapeutics, Inc. operating lease, payments for the quarter ending 2020-06-30 was $1.90M, a 5.56% increase year-over-year.
- Five Prime Therapeutics, Inc. operating lease, payments for the quarter ending 2020-03-31 was $1.90M, a 58.33% increase year-over-year.
- Five Prime Therapeutics, Inc. operating lease, payments for fiscal 2020 was $7.86M, a 17.36% increase from fiscal 2019.
- Five Prime Therapeutics, Inc. operating lease, payments for fiscal 2019 was $6.69M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $4.05M derived: sum of 2 quarters · filed 2021-03-22 | $5.96M derived: sum of 3 quarters · filed 2021-03-22 | $7.86M 10-K · filed 2021-03-22 | |
| 2020-09-30 | $2.20M 10-Q · filed 2020-11-03 | $4.10M derived: sum of 2 quarters · filed 2020-11-03 | $6.00M 10-Q · filed 2020-11-03 | $7.79M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-06-30 | $1.90M 10-Q · filed 2020-08-06 | $3.80M 10-Q · filed 2020-08-06 | $5.59M derived: sum of 3 quarters · filed 2021-03-22 | $7.49M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-03-31 | $1.90M 10-Q · filed 2020-05-07 | $3.69M derived: sum of 2 quarters · filed 2021-03-22 | $5.59M derived: sum of 3 quarters · filed 2021-03-22 | $7.39M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2019-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $3.69M derived: sum of 2 quarters · filed 2021-03-22 | $5.49M derived: sum of 3 quarters · filed 2021-03-22 | $6.69M 10-K · filed 2021-03-22 | $6.70M 10-K · filed 2020-02-27 |
| 2019-09-30 | $1.90M 10-Q · filed 2020-11-03 | $3.70M derived: sum of 2 quarters · filed 2020-11-03 | $4.90M 10-Q · filed 2020-11-03 | ||
| 2019-06-30 | $1.80M 10-Q · filed 2020-08-06 | $3.00M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $1.20M 10-Q · filed 2020-05-07 |